Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Edwards

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Rheumatology (Oxford, England)|November 30, 2010
Mortality in Wegener's granulomatosis: a bimodal patternRaashid Luqmani, Ravi Suppiah, Christopher J Edwards, et al.
BMJ (Clinical Research Ed.)|June 14, 2015
Clinician engagement is critical to public engagement with clinical trialsChristopher J Stock, Nick Carley, Ben Hickman, et al.
Rheumatology and Therapy|December 23, 2025
Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL StudyRieke Alten, Andrew Östör, Christopher J Edwards, et al.
The Journal of Rheumatology. Supplement|September 3, 2014
Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviewsJohn H Y Moi, Melonie K Sriranganathan, Louise Falzon, et al.
Rheumatology Advances in Practice|February 16, 2023
Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trialsPhilip G Conaghan, Karel Pavelka, Song-Chou Hsieh, et al.
Rheumatology (Oxford, England)|September 27, 2024
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexateMaya H Buch, David Walker, Christopher J Edwards, et al.
Arthritis Care & Research|August 20, 2010
Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: a twelve-month investigationCatherine J Bowen, Lindsey Hooper, David Culliford, et al.
The Journal of Rheumatology. Supplement|September 3, 2014
Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviewsAlison S Kydd, Rakhi Seth, Rachelle Buchbinder, et al.
Rheumatology (Oxford, England)|October 3, 2009
The clinical importance of ultrasound detectable forefoot bursae in rheumatoid arthritisCatherine J Bowen, David Culliford, Keith Dewbury, et al.
Rheumatology (Oxford, England)|April 11, 2018
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trialAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Rheumatology (Oxford, England)|November 30, 2010
Mortality in Wegener's granulomatosis: a bimodal patternRaashid Luqmani, Ravi Suppiah, Christopher J Edwards, et al.
BMJ (Clinical Research Ed.)|June 14, 2015
Clinician engagement is critical to public engagement with clinical trialsChristopher J Stock, Nick Carley, Ben Hickman, et al.
Rheumatology and Therapy|December 23, 2025
Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL StudyRieke Alten, Andrew Östör, Christopher J Edwards, et al.
The Journal of Rheumatology. Supplement|September 3, 2014
Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviewsJohn H Y Moi, Melonie K Sriranganathan, Louise Falzon, et al.
Rheumatology Advances in Practice|February 16, 2023
Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trialsPhilip G Conaghan, Karel Pavelka, Song-Chou Hsieh, et al.
Rheumatology (Oxford, England)|September 27, 2024
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexateMaya H Buch, David Walker, Christopher J Edwards, et al.
Arthritis Care & Research|August 20, 2010
Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: a twelve-month investigationCatherine J Bowen, Lindsey Hooper, David Culliford, et al.
The Journal of Rheumatology. Supplement|September 3, 2014
Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviewsAlison S Kydd, Rakhi Seth, Rachelle Buchbinder, et al.
Rheumatology (Oxford, England)|October 3, 2009
The clinical importance of ultrasound detectable forefoot bursae in rheumatoid arthritisCatherine J Bowen, David Culliford, Keith Dewbury, et al.
Rheumatology (Oxford, England)|April 11, 2018
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trialAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.
Pageof 20